IOL Chemicals & Pharmaceuticals Ltd Share Price
As of 21 Sept 2026, IOL Chemicals & Pharmaceuticals Ltd share price is ₹203.95. The stock opened at ₹203.95 and had closed at ₹202.95 the previous day. Over the last 52 weeks, the stock has recorded a low of ₹67.14 and a high of ₹219.05. In terms of performance, IOL Chemicals & Pharmaceuticals Ltd share price has increased by 173.30% over the past six months and has increased by 73.85% over the last year.
IOLCP Stock Price Chart
IOL Chemicals & Pharmaceuticals Ltd Overview
About IOLCP
IOL Chemicals & Pharmaceuticals is engaged in the manufacturing and selling of Pharmaceutical and Chemical products.
IOL Chemicals & Pharmaceuticals Ltd Historical Performance
IOL Chemicals & Pharmaceuticals Ltd Fundamentals
IOL Chemicals & Pharmaceuticals Ltd Financials
| Indicator | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Revenue | 2,340.34 | 2,101.61 | 2,162.86 | 2,242.68 | 2,216.06 |
| EBITDA | 279.16 | 224.57 | 261.59 | 252.09 | 274.39 |
| Net Profit | 137.72 | 101.00 | 135.42 | 139.98 | 165.66 |
| EPS | 4.69 | 17.20 | 23.07 | 23.84 | 28.22 |
IOL Chemicals & Pharmaceuticals Ltd Technical Analysis
| Indicator | Value |
|---|---|
| Support 1 (S1) | 197.35 |
| Resistance 1 (R1) | 207.20 |
| Pivot Point | 201.60 |
IOL Chemicals & Pharmaceuticals Ltd Dividend History
| Ex Date | Dividends Date | Record Date | Dividend Type | Dividend Details |
|---|---|---|---|---|
| 17-Feb-2026 | 11-Feb-2026 | 17-Feb-2026 | Interim | ₹1.00 |
| 18-Feb-2025 | 12-Feb-2025 | 18-Feb-2025 | Interim | ₹4.00 |
| 16-Feb-2024 | 06-Feb-2024 | 16-Feb-2024 | Interim | ₹5.00 |
| 17-Feb-2023 | 07-Feb-2023 | 17-Feb-2023 | Interim | ₹4.00 |
| 15-Feb-2022 | 04-Feb-2022 | 16-Feb-2022 | Interim | ₹4.00 |
IOLCP Key Leadership Details
Last Updated: Mar 2026
| Name | Position |
|---|---|
| R M Malla | Chairman |
| Varinder Gupta | Managing Director |
| Vikas Gupta | Executive Directorector / JMD / WTD |
IOL Chemicals & Pharmaceuticals Ltd Peer Comparison
| Company | Price | M.Cap (Cr) | P/E (TTM) | ROE (TTM) |
|---|---|---|---|---|
| Sun Pharmaceutical Industries LtdSUNPHARMA | ₹1,868.80+1.71% | ₹4,19,727.66 | 38.32 | 13.74% |
| Divis Laboratories LtdDIVISLAB | ₹9,399.00+0.26% | ₹1,67,235.91 | 67.46 | 15.32% |
| Torrent Pharmaceuticals LtdTORNTPHARM | ₹4,950.00+2.27% | ₹1,46,951.32 | 64.68 | 25.49% |
Disclaimer
The information provided on this page is for informational purposes only and should not be construed as investment advice, recommendation, or solicitation to buy or sell any securities or financial pr...
Frequently Asked Questions
- The share price of IOL Chemicals & Pharmaceuticals Ltd today is ₹203.95 on NSE and ₹203.95 on BSE.
- The 52-week high of IOL Chemicals & Pharmaceuticals Ltd is ₹219.05, while the 52-week low is ₹67.14.
- The current market capitalisation of IOL Chemicals & Pharmaceuticals Ltd is approximately ₹5,957 crore.
- The P/E (Price-to-Earnings) ratio of IOL Chemicals & Pharmaceuticals Ltd is 17.76. The ratio may vary with changes in the share price and earnings.
- The P/B (Price-to-Book) ratio of IOL Chemicals & Pharmaceuticals Ltd is 1.18. It compares the company’s market value with its book value and can provide an indication of how the market values the company relative to its net assets.
- To buy IOL Chemicals & Pharmaceuticals Ltd shares, you first need to open a demat account before you can place an order. Here's the process:
• Open a demat account online using your PAN, Aadhaar and bank details.
• Add funds to your trading account via UPI or net banking.
• Search for IOLCP on TradeMobi or the Anand Rathi web platform.
• Place your order
• Track your holdings in the portfolio section. - Over the past 3 years, IOL Chemicals & Pharmaceuticals Ltd has delivered a return of approximately 102.46%. This return is based on the change in the share price over the specified period and may differ depending on the measurement date. Past performance does not guarantee future returns.
- The shareholding pattern of IOL Chemicals & Pharmaceuticals Ltd comprises different categories of shareholders. As of Jun 2026, the shareholding is approximately 62.28% promoters, 4.85% FIIs, 0.43% DIIs, and 26.95% public shareholders.

